Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Trends in Immunology|August 6, 2018
Humanized Mice for the Study of Immuno-OncologyPhilippe De La Rochere, Silvia Guil-Luna, Didier Decaudin, et al.Aging Cell|March 23, 2011
Age-related changes in human hematopoietic stem/progenitor cellsKlaudia Kuranda, Jacques Vargaftig, Philippe de la Rochere, et al.Journal of Extracellular Vesicles|September 11, 2014
Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated formsChristine Sedlik, James Vigneron, Lea Torrieri-Dramard, et al.Cancer Immunology Research|January 18, 2019
IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell ModulationPamela Caudana, Nicolas Gonzalo Núñez, Philippe De La Rochere, et al.Oncoimmunology|September 14, 2016
Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigenChristine Sedlik, Adèle Heitzmann, Sophie Viel, et al.Oncoimmunology|May 10, 2019
Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancerEdith Borcoman, Philippe De La Rochere, Wilfrid Richer, et al.Frontiers in Immunology|April 23, 2026
A comprehensive analysis of humanized mouse models for the study of cancer immunotherapiesPhilippe De La Rochere, Laure Loumagne, Melanie Rathaux, et al.Nature Communications|July 1, 2020
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patientsNicolas Gonzalo Núñez, Jimena Tosello Boari, Rodrigo Nalio Ramos, et al.Nature Biotechnology|January 15, 2020
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigensGeoffrey M Lynn, Christine Sedlik, Faezzah Baharom, et al.Pageof 1